Home / Spironolactone / United States
US ATC C03DA01 · updated 2 Nov 2026
Spironolactone shortage in United States
Is there a Spironolactone shortage in United States?
Yes. As of 2 Nov 2026, 2 Spironolactone products are reported short in United States, the first since 10 Dec 2025. No return date has been given. Main reason: not stated.
Also short in Spain, Ireland, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Aldactone, Tablet, 100 mg (NDC 0025-1031-31) discontinuation | Pfizer Inc. | 10 Dec 2025 | not given | Not stated |
| US | Aldactone, Tablet, 25 mg (NDC 0025-1001-31) discontinuation | Pfizer Inc. | 10 Dec 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).